Induction of nitric oxide production in mouse macrophages by Shiga toxin

Journal of Medical Microbiology

Volumn 45, Issue 2, 1996, Pages 97-102

  Yuhas, Y ^a   Kaminsky, E ^a   Mor, M ^b   Ashkenazi, Shai ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; NITRIC OXIDE; SHIGA TOXIN;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; MALE; MOUSE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SHIGELLA FLEXNERI;

EID: 0029766840     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-45-2-97     Document Type: Article

References (27)

1. DuPont HL. Shigella. Infect Dis Clin North Am 1988; 2: 599-605.
2. Barrett-Connor E, Connor JD. Extraintestinal manifestations of shigellosis. Am J Gastroenterol 1970; 53: 234-245.
3. Ashkenazi S, Dinari G, Zevulunov A, Nitzan M. Convulsions in childhood shigellosis. Clinical and laboratory features in 153 children. Am J Dis Child 1987; 141: 208-210.
4. O'Brien AD, Holmes RK. Shiga and Shiga-like toxins. Microbiol Rev 1987; 51: 1206-1220.
5. Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O'Brien AD. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 1991; 164: 344-352.
6. Louise CB, Obrig TG. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 1991; 59: 4173-4179.
7. Tarr PI. Enterocolitis associated with Shiga-like toxin production: an appropriate animal model at last? Gastroenterology 1994; 106: 540-543.
8. Fontaine A, Arondel J, Sansonetti PJ. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied using a Tox mutant of Shigella dysenteriae I. Infect Immun 1988; 56: 3099-3109.
9. Howard JG. Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae. Br J Exp Pathol 1955; 36: 439-446.
10. Keusch GT, Jacewicz M. The pathogenesis of Shigella diarrhea V. relationship of Shigella enterotoxin, neurotoxin, and cytotoxin. J Infect Dis 1975; 131 Suppl: S33-9.
11. Wiley RG, Donohue-Rolfe A, Keusch GT. Axonally transported Shigella cytotoxin is neurotoxic J Neuropathol Exp Neurol 1985; 44: 496-506.
12. Yuhas Y, Weizman A, Dinari G, Ashkenazi S. An animal model for the study of neurotoxicity of bacterial products and application of the model to demonstrate that Shiga toxin and lipopolysaccharide cooperate in inducing neurologic disorder. J Infect Dis 1995; 171: 1244-1249.
13. Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 1995; 63: 289-296.
14. Tesh VL, Ramegowda B, Samuel JE. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 1994; 62: 5085-5094.
15. Barrett TJ, Potter ME, Strockbine NA. Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb Pathog 1990; 9: 95-103.
16. Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by Shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest 1993; 92: 2110-2116.
17. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
18. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
19. Clark IA, Rockett KA, Cowden WB. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992; 340: 894-896.
20. Koprowski H, Zheng YM, Heber-Katz E et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 1993; 90: 3024-3027.
21. Campbell IL, Samimi A, Chiang C-S. Expression of inducible nitric oxide synthase: correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J Immunol 1994; 153: 3622-3629.
22. Prado D, Cleary TG, Pickering LK et al. The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis 1986; 154: 149-155.
23. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-2412.
24. Yuhas Y, Shemer I, Sarov I, Wallach D. Protection of cells from TNF cytotoxicity by tryptophan and indole. Eur Cytokine Network 1990; 1: 35-40.
25. 2 and interleukin 1 production and modulates tumor necrosis factor alpha and nitric oxide production. Infect Immun 1994; 62: 4160-4166.
26. Tatro JB, Romero LI, Beasley D, Steere AC, Reichlin S. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J Infect Dis 1994; 169: 1014-1022.
27. Barrett TJ, Potter ME, Wachsmuth IK. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 1989; 57: 3434-3437.